Oxford Biomedica and Institut Mérieux enter into exclusive negotiations for the proposed acquisition of ABL Europe
Oxford Biomedica, a leading quality and innovation-led cell and gene therapy CDMO (“Contract Development Manufacturing Organisation”) and Institut Mérieux announce that they have entered into exclusive negotiations concerning Oxford Biomedica’s proposed acquisition of ABL Europe, a Group’s company specialized in … Continued
Abdoulaye Djimdé, winner of the 2023 Christophe Mérieux Prize
Abdoulaye Djimdé receives the Christophe Mérieux 2023 Prize from Fondation Christophe et Rodolphe Mérieux – Institut de France Professor of Parasitology and Mycology in Mali, Professor Abdoulaye Djimdé is rewarded for his research program using molecular and genomic approaches to … Continued
GeNeuro press conference on long-COVID
On March 14, 2023, Institut Mérieux hosted a GeNeuro press conference on long-COVID, a major public health issue. Institut Mérieux is a reference shareholder of GeNeuro and follows with interest the development of this Franco-Swiss company, a bioMérieux spin-off created … Continued
International Prize in Planetary Health awarded to Dr. Guilherme Dias de Melo of the Institut Pasteur
The International Prize in Planetary Health was awarded this Wednesday, October 12, 2022 in Lyon to Dr. Guilherme Dias de Melo of the Institut Pasteur for his work on neurotropic viral infections and their transmission from animals to humans.This prize … Continued
Institut Mérieux and Exor announce a long-term partnership in global healthcare
Institut Mérieux, the privately held global healthcare holding of the Mérieux family, and Exor, a diversified holding company controlled by the Agnelli family, have signed a long-term partnership agreement under which Exor will acquire, by way of a reserved capital … Continued
